As Strategic Review Continues, Nanosphere Posts Increase in Q4 Loss | GenomeWeb

NEW YORK (GenomeWeb) – Nanosphere reported after the close of the market Wednesday that its fourth quarter net loss increased to $9.5 million, or $.08 per share, from $8.8 million, or $.11 per share, for the fourth quarter of 2013, as the firm continues to evaluate strategic alternatives.

Its loss per share beat the consensus Wall Street estimate of $.10.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.